Health Care Knowledge

What is Multiple Myeloma? Multiple Myeloma is a hematological malignancy that affects Plasma cells. Plasma cells are the type of WBC (White blood cells) that are found in the bone marrow. Bone marrow is a soft tissue found in most of the bones. Bone marrow is the primary site of cell production. Hematopoietic stem cells can develop in various types of cells e.g. red blood cells that carry oxygen through your body, the platelets that help with blood clotting, and the white blood cells that fight infections. Multiple Myeloma is also known as Plasma Cell Myeloma. Types of Multiple Myeloma (MM): There are 2 major types of multiple myeloma: Indolent myeloma: This type of myeloma usually develops gradually without noticeable signs and symptoms. Indolent myeloma doesn’t cause bone tumors, only small increases in M protein and M plasma cells. Solitary plasmacytoma: Solitary plasmacytoma causes a tumor to form, generally in the bone. It usually responds well to treatment, but it needs pr

Brand Name: Scarnet Active Ingredient: Foscarnet Sodium Strength: 24mg/mL (250mL)  Dosage Form: Injection Drug Class: Antiviral (Pyrophosphate Analog DNA Polymerase Inhibitor) Therapeutic Indications: Foscarnet sodium is an antiviral prescription medicinal product approved by the U.S. FDA to treat cytomegalovirus (CMV) retinitis in individuals with AIDS. The foscarnet 24mg/ml (250 ml) is also approved by FDA for the treatment of a certain type of herpes simplex virus (HSV) infection, named acyclovir-resistant mucocutaneous HSV infection, in those with weakened immune systems. Cytomegalovirus diseases; such as those affecting the eye (retinitis); and herpes simplex virus diseases can be opportunistic infections (OIs) of Human Immune Virus. An opportunistic infection is an infection that usually appears more routinely or is more severe in those with weakened immune systems; such as those with HIV, than in those with healthy immune systems.  Mechanism of Action: Foscarnet inhibits, throu